Our Sponsors

  • INVO Bioscience Announces Clinical Results - Big News

    INVO is a Long term Investment. Sow your seeds now

    Hey Guys,

    Today's  hot stock is a stock with profit chances of over a 100 % in very less time. Good news are coming for this stock and this is getting momentum. Our aim really is to get profit and nothing else. We will keep a close watch on this stock. Our strategy will be to enter in IVOB at a resonable proce tomorrow and wait for a decent profit for atleast 2 weeks to a month. 

    You can also thin kof getting around 15 to 25 % profit in a week and jump somewhere else.


    BEVERLY, Mass.--INVO Bioscience announced that CECOLFES, Colombia Fertility Center, Bogota, Colombia, the first center in Latin America to introduce the INVOcell device and the INVO procedure for treatment of infertility, made known today the results of the first 28 cycles of the INVO procedure. Of the 28 patients treated, 27 patients had embryos transferred and 10 patients became pregnant with only one patient having a multiple pregnancy. This results in a 36% ongoing pregnancy rate per cycle. The average patient age was 34 years old with an average number of 6 oocytes (eggs) retrieved per patient. “We are very happy with these initial results and the patients love being involved in the process.

    We are here to make money and we will succeed.

    God Bless,
    Be Rich. 

0 comments:

Leave a Reply

Latest Posts